Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Nerve Injuries | 6 | 2025 | 14 | 3.560 |
Why?
|
| Tissue Engineering | 11 | 2023 | 144 | 3.430 |
Why?
|
| Models, Biological | 19 | 2024 | 1217 | 3.230 |
Why?
|
| Nerve Regeneration | 7 | 2025 | 38 | 2.360 |
Why?
|
| Models, Theoretical | 8 | 2023 | 274 | 2.120 |
Why?
|
| Bioreactors | 8 | 2019 | 36 | 1.790 |
Why?
|
| Microvessels | 4 | 2024 | 18 | 1.590 |
Why?
|
| Peripheral Nerves | 5 | 2024 | 33 | 1.550 |
Why?
|
| Lyssavirus | 2 | 2022 | 2 | 1.470 |
Why?
|
| Rabies Vaccines | 2 | 2022 | 4 | 1.460 |
Why?
|
| Chiroptera | 2 | 2022 | 17 | 1.430 |
Why?
|
| Algorithms | 6 | 2024 | 1048 | 1.430 |
Why?
|
| Oxygen | 7 | 2022 | 325 | 1.380 |
Why?
|
| Models, Cardiovascular | 5 | 2024 | 79 | 1.370 |
Why?
|
| Cell Culture Techniques | 6 | 2021 | 194 | 1.190 |
Why?
|
| Microcirculation | 3 | 2020 | 58 | 1.170 |
Why?
|
| Sciatic Nerve | 3 | 2025 | 29 | 1.160 |
Why?
|
| Collagen | 4 | 2024 | 134 | 1.120 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2283 | 1.110 |
Why?
|
| Computer Simulation | 10 | 2024 | 485 | 1.080 |
Why?
|
| Rats | 12 | 2025 | 2015 | 1.020 |
Why?
|
| Rabies virus | 2 | 2022 | 9 | 0.940 |
Why?
|
| Rabies | 2 | 2022 | 8 | 0.940 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2024 | 300 | 0.940 |
Why?
|
| Elastic Modulus | 3 | 2024 | 39 | 0.930 |
Why?
|
| Ferrets | 2 | 2024 | 12 | 0.910 |
Why?
|
| Blood Pressure | 3 | 2024 | 526 | 0.860 |
Why?
|
| Aerosols | 1 | 2024 | 46 | 0.860 |
Why?
|
| Stress, Mechanical | 6 | 2024 | 111 | 0.840 |
Why?
|
| Neoplasms | 5 | 2024 | 1415 | 0.820 |
Why?
|
| Tissue Culture Techniques | 2 | 2021 | 35 | 0.810 |
Why?
|
| Animals | 29 | 2025 | 21529 | 0.790 |
Why?
|
| Rhabdoviridae Infections | 1 | 2022 | 6 | 0.770 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.740 |
Why?
|
| Ventilators, Mechanical | 2 | 2021 | 29 | 0.710 |
Why?
|
| Software | 1 | 2025 | 395 | 0.700 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2025 | 231 | 0.700 |
Why?
|
| Cross Protection | 1 | 2021 | 6 | 0.700 |
Why?
|
| Biological Transport | 3 | 2021 | 294 | 0.680 |
Why?
|
| Skin | 1 | 2024 | 425 | 0.680 |
Why?
|
| Shock | 1 | 2020 | 33 | 0.660 |
Why?
|
| Research Design | 1 | 2023 | 585 | 0.640 |
Why?
|
| Retinal Degeneration | 1 | 2020 | 28 | 0.630 |
Why?
|
| Shock, Septic | 1 | 2020 | 87 | 0.620 |
Why?
|
| Drug Therapy | 1 | 2020 | 56 | 0.620 |
Why?
|
| Global Health | 1 | 2021 | 186 | 0.610 |
Why?
|
| Humans | 46 | 2025 | 65528 | 0.590 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 171 | 0.580 |
Why?
|
| Rheology | 3 | 2019 | 83 | 0.550 |
Why?
|
| Shear Strength | 3 | 2019 | 17 | 0.510 |
Why?
|
| Pandemics | 2 | 2021 | 676 | 0.500 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 443 | 0.500 |
Why?
|
| Tissue Scaffolds | 5 | 2022 | 87 | 0.500 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 333 | 0.500 |
Why?
|
| Actins | 1 | 2018 | 262 | 0.490 |
Why?
|
| Vascular Neoplasms | 2 | 2020 | 18 | 0.470 |
Why?
|
| Cell Lineage | 2 | 2014 | 283 | 0.460 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 682 | 0.430 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 46 | 0.430 |
Why?
|
| Hydrogels | 3 | 2021 | 124 | 0.430 |
Why?
|
| Cells | 1 | 2014 | 32 | 0.430 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2021 | 33 | 0.370 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2024 | 694 | 0.360 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 147 | 0.350 |
Why?
|
| Antigens, Viral | 2 | 2021 | 137 | 0.320 |
Why?
|
| Chemotaxis | 2 | 2024 | 51 | 0.320 |
Why?
|
| Computational Biology | 2 | 2024 | 364 | 0.310 |
Why?
|
| Capillaries | 3 | 2024 | 30 | 0.310 |
Why?
|
| Brain | 1 | 2018 | 1606 | 0.300 |
Why?
|
| Cell Proliferation | 5 | 2017 | 1050 | 0.290 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 906 | 0.290 |
Why?
|
| Kinetics | 4 | 2021 | 769 | 0.290 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 99 | 0.280 |
Why?
|
| Morphogenesis | 1 | 2009 | 119 | 0.280 |
Why?
|
| Blastocyst | 1 | 2009 | 75 | 0.280 |
Why?
|
| Mathematical Concepts | 3 | 2020 | 4 | 0.280 |
Why?
|
| Retinal Vessels | 2 | 2025 | 18 | 0.270 |
Why?
|
| Diabetic Retinopathy | 2 | 2025 | 56 | 0.270 |
Why?
|
| Hemodynamics | 2 | 2020 | 253 | 0.270 |
Why?
|
| Hydrodynamics | 3 | 2018 | 41 | 0.260 |
Why?
|
| Endocytosis | 2 | 2021 | 153 | 0.260 |
Why?
|
| Retina | 2 | 2025 | 134 | 0.260 |
Why?
|
| Biomechanical Phenomena | 3 | 2024 | 283 | 0.240 |
Why?
|
| Eyelids | 2 | 2017 | 9 | 0.240 |
Why?
|
| Mice | 6 | 2025 | 11215 | 0.230 |
Why?
|
| Cell Survival | 2 | 2020 | 601 | 0.230 |
Why?
|
| Biocompatible Materials | 3 | 2021 | 153 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2024 | 630 | 0.230 |
Why?
|
| Cell Line | 2 | 2021 | 2071 | 0.220 |
Why?
|
| Fomites | 1 | 2024 | 4 | 0.220 |
Why?
|
| Oxygen Consumption | 3 | 2019 | 213 | 0.220 |
Why?
|
| Tigers | 1 | 2024 | 2 | 0.210 |
Why?
|
| Animals, Zoo | 1 | 2024 | 2 | 0.210 |
Why?
|
| Glycoproteins | 1 | 2025 | 190 | 0.210 |
Why?
|
| Placenta | 1 | 2024 | 68 | 0.210 |
Why?
|
| Information Dissemination | 1 | 2025 | 115 | 0.210 |
Why?
|
| Regional Blood Flow | 3 | 2020 | 116 | 0.210 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 271 | 0.210 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 70 | 0.200 |
Why?
|
| Phylogeny | 2 | 2024 | 395 | 0.200 |
Why?
|
| Biophysics | 1 | 2023 | 42 | 0.200 |
Why?
|
| Uncertainty | 1 | 2023 | 40 | 0.200 |
Why?
|
| Minocycline | 1 | 2023 | 28 | 0.200 |
Why?
|
| Swine | 1 | 2024 | 398 | 0.200 |
Why?
|
| Recovery of Function | 1 | 2025 | 295 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2023 | 125 | 0.200 |
Why?
|
| Pericytes | 2 | 2025 | 16 | 0.200 |
Why?
|
| Cardiovascular System | 1 | 2023 | 40 | 0.200 |
Why?
|
| RNA, Viral | 1 | 2024 | 273 | 0.200 |
Why?
|
| Taiwan | 1 | 2022 | 13 | 0.190 |
Why?
|
| Machine Learning | 1 | 2025 | 195 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 217 | 0.190 |
Why?
|
| Heart Ventricles | 1 | 2024 | 267 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 122 | 0.180 |
Why?
|
| Cumulus Cells | 1 | 2021 | 6 | 0.180 |
Why?
|
| Seroconversion | 1 | 2021 | 6 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 1611 | 0.170 |
Why?
|
| Manufacturing Industry | 1 | 2021 | 3 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 332 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 49 | 0.170 |
Why?
|
| Diffusion | 3 | 2021 | 82 | 0.170 |
Why?
|
| Materials Testing | 3 | 2019 | 87 | 0.170 |
Why?
|
| Models, Neurological | 1 | 2021 | 82 | 0.170 |
Why?
|
| Immunization | 1 | 2021 | 137 | 0.170 |
Why?
|
| International Cooperation | 1 | 2021 | 91 | 0.170 |
Why?
|
| Policy | 1 | 2021 | 56 | 0.160 |
Why?
|
| Heart | 2 | 2014 | 295 | 0.160 |
Why?
|
| Noninvasive Ventilation | 1 | 2021 | 69 | 0.160 |
Why?
|
| Splanchnic Circulation | 1 | 2020 | 16 | 0.160 |
Why?
|
| Mesentery | 1 | 2020 | 17 | 0.160 |
Why?
|
| Polymers | 2 | 2013 | 331 | 0.160 |
Why?
|
| Blepharoptosis | 2 | 2017 | 6 | 0.150 |
Why?
|
| Virus Replication | 1 | 2021 | 325 | 0.150 |
Why?
|
| Extracellular Fluid | 1 | 2019 | 11 | 0.150 |
Why?
|
| Xenobiotics | 1 | 2019 | 13 | 0.150 |
Why?
|
| Drug Carriers | 1 | 2021 | 186 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2018 | 103 | 0.140 |
Why?
|
| Equipment Design | 3 | 2020 | 362 | 0.140 |
Why?
|
| Numerical Analysis, Computer-Assisted | 2 | 2015 | 6 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 299 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 142 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 110 | 0.140 |
Why?
|
| Optogenetics | 1 | 2018 | 32 | 0.140 |
Why?
|
| Blinking | 2 | 2017 | 4 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 208 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 222 | 0.130 |
Why?
|
| Nanoparticles | 2 | 2021 | 534 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 72 | 0.130 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 28 | 0.130 |
Why?
|
| Coronary Circulation | 2 | 2014 | 55 | 0.120 |
Why?
|
| Cattle | 1 | 2017 | 321 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2017 | 99 | 0.120 |
Why?
|
| Coronary Vessels | 2 | 2014 | 124 | 0.120 |
Why?
|
| Liver | 1 | 2019 | 879 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 157 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 14 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1310 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 122 | 0.100 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2013 | 9 | 0.100 |
Why?
|
| Sutures | 1 | 2013 | 41 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 38 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 129 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 42 | 0.100 |
Why?
|
| Female | 7 | 2024 | 34125 | 0.100 |
Why?
|
| Cell Death | 1 | 2014 | 290 | 0.100 |
Why?
|
| Video Recording | 1 | 2013 | 142 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2014 | 420 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 165 | 0.090 |
Why?
|
| Glucuronic Acid | 1 | 2011 | 20 | 0.090 |
Why?
|
| Hexuronic Acids | 1 | 2011 | 23 | 0.090 |
Why?
|
| Alginates | 1 | 2011 | 50 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2011 | 75 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2211 | 0.080 |
Why?
|
| Child | 1 | 2020 | 4678 | 0.080 |
Why?
|
| Porosity | 3 | 2019 | 41 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1398 | 0.080 |
Why?
|
| Capillary Permeability | 1 | 2008 | 16 | 0.070 |
Why?
|
| Glucose | 1 | 2011 | 478 | 0.070 |
Why?
|
| Tensile Strength | 2 | 2019 | 32 | 0.060 |
Why?
|
| Computer Security | 1 | 2025 | 16 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 3482 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2025 | 181 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 206 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2025 | 3157 | 0.050 |
Why?
|
| Zoonoses | 1 | 2024 | 9 | 0.050 |
Why?
|
| England | 1 | 2024 | 30 | 0.050 |
Why?
|
| Cats | 1 | 2024 | 92 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2023 | 9 | 0.050 |
Why?
|
| Respiratory System | 1 | 2023 | 48 | 0.050 |
Why?
|
| Dog Diseases | 1 | 2024 | 64 | 0.050 |
Why?
|
| Biomarkers | 1 | 2009 | 1471 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 340 | 0.050 |
Why?
|
| Cell Movement | 1 | 2024 | 480 | 0.040 |
Why?
|
| Heart Rate | 1 | 2023 | 331 | 0.040 |
Why?
|
| Male | 5 | 2023 | 31073 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2024 | 194 | 0.040 |
Why?
|
| RNA Probes | 1 | 2020 | 9 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2021 | 128 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 137 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 18266 | 0.040 |
Why?
|
| Lentivirus | 1 | 2021 | 67 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 81 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 216 | 0.040 |
Why?
|
| Myocardium | 2 | 2014 | 298 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 117 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 460 | 0.040 |
Why?
|
| Neurites | 1 | 2019 | 23 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 174 | 0.040 |
Why?
|
| Tendons | 1 | 2019 | 25 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 14946 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2019 | 110 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 582 | 0.040 |
Why?
|
| Transplants | 1 | 2018 | 9 | 0.040 |
Why?
|
| Diphosphates | 1 | 2018 | 12 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2018 | 27 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2018 | 17 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 30 | 0.040 |
Why?
|
| Nerve Transfer | 1 | 2018 | 9 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2019 | 57 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2018 | 187 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2018 | 63 | 0.030 |
Why?
|
| Stilbenes | 1 | 2018 | 51 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 291 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 243 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 279 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1173 | 0.030 |
Why?
|
| Gadolinium | 1 | 2018 | 110 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2018 | 100 | 0.030 |
Why?
|
| Glioma | 1 | 2018 | 101 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2019 | 225 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 2432 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 200 | 0.030 |
Why?
|
| Forehead | 1 | 2017 | 16 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 205 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 30 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1701 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 878 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 17418 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 433 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 281 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2014 | 21 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 64 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 63 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 184 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 28 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 43 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 52 | 0.030 |
Why?
|
| Hardness | 1 | 2013 | 8 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2014 | 36 | 0.030 |
Why?
|
| Quinolines | 1 | 2014 | 48 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2013 | 18 | 0.030 |
Why?
|
| Oculomotor Muscles | 1 | 2013 | 11 | 0.030 |
Why?
|
| Rhodamines | 1 | 2013 | 20 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 86 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 90 | 0.030 |
Why?
|
| Clathrin | 1 | 2013 | 23 | 0.030 |
Why?
|
| Muscles | 1 | 2014 | 180 | 0.030 |
Why?
|
| Neurons | 1 | 2019 | 949 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 79 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2013 | 28 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2013 | 24 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 80 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 311 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 197 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 209 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4836 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1020 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2009 | 19 | 0.020 |
Why?
|
| Physics | 1 | 2009 | 12 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 6 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2008 | 29 | 0.020 |
Why?
|
| Biology | 1 | 2009 | 26 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3789 | 0.020 |
Why?
|